patients are impaired in the same gene as classical RCDP patients. We conclude that defects in a single gene can give rise to both clinical phenotypes.
Introduction
The rhizomelic form of splasia punctata recessive maractens (RCDP) is an clinically by symmetrical shortening of the proximal ex tremities, congenital contractures, typical craniofacial dysmorphism with characteristic ocular involvement, severe mental and growth retardation and typical radiological abnormalities [1, 2] . RCDP was assigned to the peroxiso mal disease category after finding an impaired plasmalogen (ether phospholipid) synthesis [3] . The biochemical abnormalities in RCDP are now known to include (i) a (partial) deficiency of dihydroxyacetonephosphate acyltransferase; a deficiency of •oxy acetone phosphate synthase; (iii) an elevation of phytanic acid due to the deficient «-oxidation of phytanic acid and (iv) the presence of peroxisomal thiolase in precursor form . [ 
2-~6].
Abbreviations: RCDP, rhizomelic form of chondrodysplasia punctata; CDP, chondrodysplasia punctata; CAT, chloramphenicol aeetyltrunsfera.se Corresponding author. Fax: + 31 20 6915519.
These deficiencies are likely to be the indirect result of a defect in a single gene, the protein product of which may be involved in the import of these enzymes into peroxi-\s.
Although the above-mentioned subset of peroxisomal ox i somes in RCD1
S IS in j fibroblasts have been shown to be morphologically normal and capable of importing ealalase [7] and peroxisomal proteins containing the (C-terminal) peroxisome targeting signal type I (PTS I ) [8] . However, proteins containing the type 2 peroxisome targeting signal (PTS2) (present in the presequence of peroxisomal thiolase) are not imported into peroxisomes in RCDP cells Several patients have been described recently who show chondrodysplasia punctata without the rhizomelic dwarfism (non-rhizomelic CDP), but biochemically show all peroxisomal deficiencies characteristic of RCDP [9] [10] [11] [12] . It was ore examine me classical fall into non-rhizomelic CDP patients and the patients which we have earlier found to î 1 nrire com plem entation trrour) i 13l. W e have done this using complementation analysis following 0 9 2 5 -4 4 3 9 /9 6 /$ 15.00 © 1996 Elsevier Science B.V. All rights reserved SSD I 0 9 2 5 -4 4 3 9 (9 5 )0 0 1 14-X * . •*/ W a ? .
. .
iw -i
Vs, 
. ;.' I :; axes were visualised using the ECL kit from Amersham.
Results
Fibroblasts from each of the patients were tested for their ability to import reporter proteins for the type 1 and 2 peroxisome targeting signals (Iuciferase and prethiolase-CAT, respectively) into their peroxisomes. A particulate pattern of labelling was seen in control fibroblasts after expression of both Iuciferase (Fig. 1A) and prethiolase-CAT (Fig. 1C) ; both these reporter proteins have previ ously been shown to co-localise with endogenous peroxi somal proteins [8] . The PTS1 reporter protein Iuciferase has previously been shown to be imported into peroxi somes in RCDP cells [8] .
s reporter protein is als to peroxisomes in cell lines CDPI-4. Fig. IB shows the expression pattern in CDP1 cells.
In contrast to the PTS1 reporter protein, expression of the PTS2 reporter protein in CDPI cells gave rise to a diffuse pattern of labelling resembling a cytoplasmic local isation (Fig. ID) . Labelling patterns similar to the latter were observed with cell lines CDP2-4 (not shown) and have also been observed in cells derived from classical RCDP patients [8] , The labelling patterns seen after ex pression of prethiolase-CAT were similar to those seen when endogenous thiolase was visualised using a mono clonal antibody (Fig. 1E,F) .
Thiolase import was assessed further by determining the accessibility of endogenous peroxisomal thiolase to pro tease digestion. Precursor thiolase is protected from pro tease digestion in fibroblasts from a neonatal , upper pi import of precursor thiolase has been shown to be intact [8] . In all of the CDP patients (of which CDPI is shown in by Fig. 2, lower panel) , precursor thiolase is K, presumably because of its failure to be imported into peroxisomes.
The genetic relationship between the four CDP patients and a classical RCDP patient was investigated by comple mentation analysis after somatic cell fusion of different combinations of fibroblasts. As has been :
by Heikoop et al. [13] , the appearance of punctate fluorescence using a monoclonal anti-thiolase antibody can be taken as a mor phological criterion to indicate complementation. When fibroblasts from a Zellweger patient were fused with CDP I fibroblasts, a punctate pattern of fluorescence was seen in the heterokaryons (Fig. 3A) . Similar results were obtai after fusion of CDP2-4 with ZS cells (not shown). In contrast to the fusions with ZS fibroblasts, no punctate fluorescence could be observed when different, pairwise combinations of fibroblasts from the CDP patients were fused with each other, indicating that cell lines CDP 1-4 all belong to the same complementation group. Fig. 3B shows the labelling pattern 18 h after fusion of cell lines CDPI and CDP2.
In order to investigate whether the CDP patients are deficient in the same gene as that deficient in classical RCDP patients, cell lines CDP 1-4 were each fused with a representative cell line from the large complementation group that contains fibroblasts from 9 classical RCDP was seen i patients [13] . No punctate fusions between CDP and classical RCDP cell lines, indi cating that all ines are deficient in the same gene. 
Discussion
The non-i in this study have previously the biochemical abnormalities ;tata patients shown to aracteristic of
non-rhizomclie
We have c patients to from a classical RCDP patient with respect to their ability to import the PTS I-containing protein Iuciferase and the PTS2-containing protein thiolase. We have also investigated the genetic relationship between non-rhizomelic CDP patients and a classical RCDP patient using complementation analysis after somatic cell fusion. Fibroblasts from the classical RCDP patient have already been shown to belong to the same complementation group as 8 other patients with the clinical manifestations of RCDP [13] .
The ability of CDP and RCDP cells to i shows that the PTS1 import route is intact in these cells. Analysis of (i) the subcellular localisation of a reporter protein for the thiolase i rescence and (ii) the i m s to degradation has shown that precursor thiolase in both RCDP and non-rhizomelic CDP fibroblasts failed to be imported into peroxisomes. We conclude from the above that the non-rhi; patients cannot be distinguished from the classical RCDP patient either with respect to their ability to import the PTS 1-containing reporter protein Iuciferase, or with re spect to their inability to import PTS2-containing peroxiso mal thiolase.
It was therefore of interest to investigate <** rei at i on sh i p between RCDP and the CDP patients. The failure of punctate thiolase labelling to after fusion of various alions of non rhizomelic CDP fibroblasts and RCDP fibroblasts (in con trast to when Zellweger fibroblasts were used as a fusion c partner) indicates that the non-rhi/; fibroblasts all belong to the same complementation group. It is striking that defects within one and the same gene can rise to both the rhizomelic and the non-rhizomelic forms of CDP. It is possible that the mutations present in non-rhizomelic CDP patients give rise to a protein :t with higher residual activity than that found in the more severe RCDP patients, as at least one of the CDP patients [9] had higher DHAP-AT activity than that found in RCDP patients. Support for this possibility is provided by Wanders et al., who have described two patients [17, 18] who showed all the clinical features of RCDP but lacked the tetrad of biochemical abnormalities usually found in RCDP patients: in both patients, phytanic acid oxidation was normal, and thiolase was present in its mature form inside peroxisomes. However, both patients showed a defi ciency in plasmalogen biosynthesis: in one patient, the first enzyme required for plasmalogen biosynthesis was defi cient (DHAP-AT) [17] , while the other patient lacked only the second enzyme [18] . These results strongly suggest that the pathogenesis of RCDP is directly related to the inabil ity to synthesise plasmalogens [17, 18] . The finding that patients suffering from non-rhizome!ic and rhizomelic CDP have a deficiency in the same gene indicates that the former is simply a milder form of the latter. A complementation group which includes patients suffering from the peroxisomal disorders Zellweger Syn drome, Infantile Refsum 's disease and neonatal adrenoleukodystrophy shows that phenotypic heterogeneity within a single complementation group is not unprece dented [15, [19] [20] [21] ,
